Emergent Biosolutions
EBS
EBS
353 hedge funds and large institutions have $3.96B invested in Emergent Biosolutions in 2020 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 154 increasing their positions, 110 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 358 → 353 (-5)
11% less capital invested
Capital invested by funds: $4.45B → $3.96B (-$494M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
353
Holding in Top 10
2
Calls
$18.6M
Puts
$18.4M
Top Buyers
| 1 | +$84.6M | |
| 2 | +$37.2M | |
| 3 | +$34.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$25.4M |
Top Sellers
| 1 | -$64.8M | |
| 2 | -$35.6M | |
| 3 | -$35.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$31.2M |
| 5 |
Two Sigma Investments
New York
|
-$28.7M |